Zhaoyang Niu

Title: Zhaoyang Niu: Innovator in Neurodegenerative Disease Treatment

Introduction

Zhaoyang Niu is a prominent inventor based in Hanover, NH (US). He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patented methods. With a total of 3 patents, Niu is dedicated to advancing medical science and improving treatment options for patients.

Latest Patents

Niu's latest patents focus on methods for selectively inhibiting Acyl-CoA: Cholesterol Acyltransferase 1 (ACAT1) in the treatment of neurodegenerative diseases. The first patent describes methods for stimulating the clearance of misfolded or aggregated proteins or peptides in microglia or neurons. This approach aims to treat neurodegenerative diseases associated with such pathology in the brain by selectively inhibiting the expression or activity of ACAT1, while sparing Acyl-CoA: Cholesterol Acyltransferase 2. The second patent reiterates similar methods, emphasizing the importance of targeting ACAT1 to enhance therapeutic outcomes.

Career Highlights

Zhaoyang Niu is affiliated with Dartmouth College, where he conducts his research and develops his innovative methods. His work has garnered attention in the scientific community, contributing to the understanding and treatment of neurodegenerative diseases.

Collaborations

Niu collaborates with esteemed colleagues, including Ta-Yuan Chang and Catherine C Y Chang. These partnerships enhance the research efforts and broaden the impact of their findings in the field.

Conclusion

Zhaoyang Niu's contributions to the treatment of neurodegenerative diseases through his patented methods highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and patient care.